Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff ...

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim ... Takeda’s president, chief executive officer (CEO) and ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Takeda Pharmaceutical 45020.65%increase; green up pointing triangle raised its annual earnings forecasts despite posting lower quarterly net profit, and it said Julie Kim, who heads its U.S ...

Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim ... Takeda’s president, CEO and representative director, when Weber retires from the ...

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business ... president of its U.S. business unit, will succeed CEO Christophe Weber, who plans to step down in June next year.

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S. business unit. As part of the executive transition, Weber will retire in June ...

Julie Kim Representative Director, President & Chief Executive Officer* President, U.S. Business Unit and U.S. Country Head Christophe Weber Retirement Representative Director, President & Chief ...

announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s ...

Credit: Michael Vi/Shutterstock. Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026.